>Neutral stance reiterated, adjusting estimates and valuation to recent developments - We reiterate our Neutral stance on Fluidra as we believe the group’s strong fundamentals are fairly reflected in its valuation multiples (>12x EV/ EBITDA 2025e, c.5.5% FCF yield) and that the gradual normalisation of results is factored into the company’s financial guidance and consensus estimates. We are slightly lowering our 2024 estimates (adjusted EBITDA -5%) to reflect some one...
NEWS SUMMARY: FLUIDRA, OHLA. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’24 results to be released over the coming days in Spain. Calm ahead of the elections It was a calm session with moderate corrections in Europe ahead of the US elections (with a tight race) and the Fed meeting to be held next Thursday. In the STOXX 600, Banks and Energy saw the biggest gains vs. Tech...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: FLUIDRA, NATURGY, OHLA. EUROPA: DHL GROUP. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. Calma antes de las elecciones Sesión de poco movimiento y cautela con caídas moderadas en Europa en la jornada previa a las elecciones en Estados Unidos...
3Q'24 vs. 3Q'23 Results Sales: € 466.0 M (+6.6% vs. +7.9% BS(e) and +4.8% consensus); EBITDA: € 90.21 M (+15.7% vs. +14.4% BS(e) and +11.8% consensus); Net Profit: € 82.0 M (+182.8%). 9M'24 vs. 9M'23 Results Sales: € 1.637 Bn (+0.9% vs. +1.2% BS(e) and +0.4% consensus); EBITDA: € 386.0 M (+5.5% vs. +5.2% BS(e) and +4.6% consensus); Net Profit: € 194.0 M (+7.8%).
>Results broadly in line with estimates (higher sales, lower margins) - Results broadly in line with our estimates and consensus estimates (-1.3% and +0.8% respectively at adjusted EBITDA in 9M 2024), with sales growth across all regions and Europe returning to growth since Q1 2022. EBITDA margin stands at 23.6% (+100bp above 9M 2023 figures but still somewhat below our estimates). Q3 2024 EBITDA margin stood at 19.3% down from 25.3% in H1 2024 (but up from 17.8% in Q...
Rdos. 3T'24 vs 3T'23: Ventas: 466,0 M euros (+6,6% vs +7,9% BS(e) y +4,8% consenso); EBITDA: 90,21 M euros (+15,7% vs +14,4% BS(e) y +11,8% consenso); BDI: 82,0 M euros (+182,8% vs n/a BS(e) y n/a consenso). Rdos. 9meses'24 vs 9meses'23: Ventas: 1.637 M euros (+0,9% vs +1,2% BS(e) y +0,4% consenso); EBITDA: 386,0 M euros (+5,5% vs +5,2% BS(e) y +4,6% consenso); BDI: 194,0 M euros (+7,8% vs n/a BS(e) y n/a consenso).
BARCELONA, Spain--(BUSINESS WIRE)-- Fluidra, the global leader in equipment and connected solutions in the pool and wellness sector, achieved sales of €1,637 million in the first nine months of 2024, up 1%. With this performance, the Group returns to growth, on the back of strong Q3 sales driven by higher volumes. EBITDA of €386 million, with 23.6% margin, was up 5.6% despite inflation in operating expenses. This was due to strong gross margin expansion, driven by the Simplification Program, together with positive geographic mix effects and lower raw material costs. Cash Net Profit reached 1...
NEWS SUMMARY: BANKING/ENERGY SECTOR, CAIXABANK, EBRO FOODS, FCC, FLUIDRA, NATURGY. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 3Q’24 results to be released over the coming days in Spain. Inflation rises in October European stock markets fell, with October’s inflation data in Europe higher than expected. In the STOXX 600, all the sectors ended with drops, with Travel & Leisu...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAIXABANK, EBRO FOODS, FCC, FLUIDRA, NATURGY, SECTOR BANCOS, SECTOR ENERGÉTICO. EUROPA: AB INBEV, AXA, AIRBUS, DHL GROUP, ING, SIEMENS. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 3T’24 que se publicarán en España y Europa en los próximos días. La inflación repunta en octubre Caídas en los mercados euro...
We are removing GSK from our European Large Caps Convictions List. The company is the only one of the six Big Pharma groups to have experienced a break in trend, which could act as a drag on future publications. Our analyst adjusted this morning his EPS estimates for 2024/2025/2026 by -0.6%, 2.0% and- 3.4% respectively, factoring in weaker growth for Arexvy and Shingrix, hence the lowering of his target price from 2,150p to 1,900p. - ...
Nous sortons GSK de notre liste de valeurs recommandées Large Caps. La société est la seule des 6 big Pharma à connaître une rupture de tendance qui pourrait peser lors des prochaines publications. Notre analyste ajuste ce jour ses prévisions de BPA 24/25/26 de -0.6%/-2.0%/-3.4% intégrant une plus faible croissance pour Arexvy et Shingrix, ce qui conduit à une baisse de son objectif de cours de 2 150p à 1 900p. - ...
>Margin pressure on higher chemical sales - Fluidra is due to release its Q3 2024 results on 31 October and hold a conference call the same day at 10:00 (CET). The new CEO (Jaime Ramirez) will take an active part in the presentation together with Fluidra’s Chairman and CFO. We expect resilient aftermarket business to sustain revenues in Q3 2024 despite the prolonged weakness of the newbuild segment while margins are likely to decline compared to H1 2024 levels (25.3%)...
We host our 4th ODDO BHF Iberian Forum on the 1st and 2nd of October 2024 virtually. In total, 63 companies will be presenting. In the following note, we provide some initial feedback of the company on day 1. - >Acciona (=) : Confidence in Non-energy business steady, Acciona Energía stake sparks intense scrutiny - Acciona Energia (=/-) : A trajectory beyond 2024 to be explained at the 9 months results - Acerinox (=/-): Softness persists in Europe and US - Amadeus (=/+): sol...
A director at Fluidra S.A. sold 10,000 shares at 22.510EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
NEWS SUMMARY: FLUIDRA. The Ibex exceeds the 11,000-point level, opening the door to further rises It was a session of gains on both sides of the Atlantic, positive for cyclical and value stocks, with the Ibex standing out among the best-performing indices. In the STOXX 600, Basic Resources and Retail led the gains, whereas Technology and Food saw the lowest rises. On the macro side, no relevant macro references were released but this morning China, as expected, kept 1 & 5-year loan rates at 3.3...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.